Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum
Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum
Active, not recruiting · NCT04589650 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum | PIK3CA-related Overgrowth Spectrum (PROS) | Active, not recruiting | Phase 2 | 2026-10-07 | NCT04589650 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine | Houston | United States | 306 |
| Childrens Hospital and Regional Medical Center | Seattle | United States | 3 |
| Childrens Hospital Colorado | Aurora | United States | 23 |
| CHOP Abramson Pediatric Resch Ctr | Philadelphia | United States | 2 |
| Cincinnati Children s Hospital Medical Center | Cincinnati | United States | 1 |
| Cinn Children Hosp Medical Center | Cincinnati | United States | 10 |
| Fink Childrens Ambulatory Care Ctr | New York | United States | 1 |
| UCSF Birthmarks and Vascular Center | San Francisco | United States | 1 |
| University of North Carolina at Chapel Hill | Chapel Hill | United States | 129 |
| Unv of TX Southwestern Medical Center | Dallas | United States | 1 |
| Washington Univ School Of Medicine | St Louis | United States | 4 |